Choose Your Country or Region

Australia
Austria
Belgium
Brazil
Canada
China
Czech Republic
Denmark
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Ireland
Israel
Italy
Japan
Korea
Luxembourg
Malaysia
Netherlands
New Zealand
Norway
Poland
Qatar
Romania
Saudi Arabia
Singapore
Spain
Sweden
Switzerland
Taiwan
Turkey
United Kingdom
United States

gp120/CD4

Other Immunology & Inflammation Related Inhibitors

CXCR AhR STING COX IL Receptor NOD NADPH-oxidase ROS Nrf2 NOS

Cat.No.	Product Name	Information	Product Use Citations
S2632	BMS-378806	BMS-378806 (BMS 806) selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus.	Commun Biol, 2025, 8(1):442 Commun Biol, 2023, 6(1):535 J Virol, 2021, 95(24):e0052921
S7220	Fostemsavir	Fostemsavir (BMS-663068, Rukobia), the phosphonooxymethyl prodrug of BMS626529, is an attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells with EC50 of < 10 nM.
S7487	YYA-021	YYA-021 is a CD4-mimic HIV entry inhibitor, competitively inhibiting the interaction between gp120 and CD4.

Cat.No.

Product Name

Information

Product Use Citations

Product Validations

S2632

BMS-378806

BMS-378806 (BMS 806) selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus.

Commun Biol, 2025, 8(1):442

Commun Biol, 2023, 6(1):535

J Virol, 2021, 95(24):e0052921

S7220

Fostemsavir

Fostemsavir (BMS-663068, Rukobia), the phosphonooxymethyl prodrug of BMS626529, is an attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells with EC50 of < 10 nM.

S7487

YYA-021

YYA-021 is a CD4-mimic HIV entry inhibitor, competitively inhibiting the interaction between gp120 and CD4.